Related Experiment Video
Updated: Apr 12, 2026
An Assay for Measuring the Activity of Escherichia coli Inducible Lysine Decarboxyase
Published on: December 19, 2010
An optimized coupled assay for quantifying diaminopimelate decarboxylase activity
Martin G Peverelli1, Matthew A Perugini1
1Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.
A new assay simplifies measuring diaminopimelate decarboxylase (DAPDC) activity, a key bacterial enzyme absent in humans. This method aids in discovering new antibacterial drugs against resistant pathogens like E. coli and M. tuberculosis.
Area of Science:
- Biochemistry
- Enzymology
- Drug Discovery
Background:
- Diaminopimelate decarboxylase (DAPDC) is crucial for lysine biosynthesis in bacteria via the diaminopimelate (DAP) pathway.
- DAPDC is absent in humans, making it a viable target for novel antibacterial agents.
- Drug-resistant bacterial strains necessitate the development of new therapeutic strategies.
Purpose of the Study:
- To optimize a quantitative assay for measuring DAPDC activity.
- To characterize the kinetic properties of DAPDC from key bacterial pathogens.
- To establish a high-throughput screening method for DAPDC inhibitors.
Main Methods:
- Enzyme kinetics assay development using saccharopine dehydrogenase (SDH) as a coupling enzyme.
- Optimization of assay conditions including temperature, pH, and buffer.
- Determination of kinetic parameters (Km and kcat) for bacterial DAPDC.
Main Results:
- Optimized SDH activity at 37 °C, pH 8.0, in Tris buffer.
- Quantified kinetic parameters for DAPDC from Escherichia coli, Mycobacterium tuberculosis, and Bacillus anthracis.
- Validated the assay's accuracy by comparing results with previous studies.
Conclusions:
- The developed coupled assay is efficient for measuring bacterial DAPDC activity.
- This assay provides crucial kinetic data for E. coli, M. tuberculosis, and B. anthracis DAPDC.
- The optimized assay is suitable for high-throughput drug discovery targeting bacterial pathogens.
